ImmunityBio, Inc. IBRX Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from ImmunityBio, Inc.’s reported figures.
Based on trailing twelve months.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s interest coverage?
- ImmunityBio, Inc. (IBRX) reported interest coverage of -5× in Q1 2026.
- How has ImmunityBio, Inc.'s interest coverage changed year-over-year?
- ImmunityBio, Inc.'s interest coverage increased by 27.4% year-over-year, from -6.9× to -5×.
- What is the long-term trend for ImmunityBio, Inc.'s interest coverage?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s interest coverage has grown at a -24.6% compound annual growth rate (CAGR), from -20.3× to -5×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.